All articles by Akosua Mireku
Akosua Mireku is a healthcare reporter for Pharmaceutical Technology. Akosua has a Bsc in medical physiology from the University of Manchester. She is particularly interested in topics in neuroscience, rare diseases, and global health equality
Akosua Mireku
@AkosuaMireku1
FDA drug dosage optimisation guidelines signal clinical trial reform
The FDA chooses drug optimisation as the preferred blueprint for cancer trials, departing from the maximum tolerated dose model.
FDA suggests ways to curb constraints with rare disease gene therapy trials
At a recent town hall, FDA experts indicated how sponsors can navigate smaller rare disease patient populations for gene therapy trials.